ASSOSIATION OF SERUM MAGNESIUM LEVELS WITH HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ON METFORMIN OR PIOGLITAZONE

  • HUWAINAN NISA NASUTION Department of Internal Medicine, Airlangga University, Surabaya, Indonesia.
  • SONY WIBISONO MUDJANARKO Department of Internal Medicine, Airlangga University, Surabaya, Indonesia.
  • DWI APRILAWATI Department of Public Health and Preventive Medicine, Airlangga University, Surabaya, Indonesia.
  • AGUNG PRANOTO Department of Internal Medicine, Airlangga University, Surabaya, Indonesia.

Abstract

Background: Magnesium is known to be associated with insulin resistance in type 2 diabetes mellitus (DM) resulting in the accelerated progression of the disease causing the risk of complications in type 2 DM. In a hypomagnesemic state, there is a decrease in the phosphorylation of insulin receptor which leads to an increase in insulin resistance.


Methods: The inclusion criteria were the patients of type 2 DM who had already used metformin or pioglitazone with a body mass index of <30 kg/m2. An examination of magnesium nutrient intake on the patients was carried out with a validated food frequency questionnaire of nutrient intake for the past 3 days by a nutritionist. Fasting plasma glucose was analyzed using Roche/Hitachi Cobas C System. Fasting insulin was analyzed using the Elecsys and Cobas E Immunoassay Analyzers. Serum magnesium level was analyzed using Roche/Hitachi Cobas C 311/501 System.


Results: The study involved 41 subjects of patients with type 2 DM. The mean of magnesium nutrient intake was still low with an average of 207.2 ± 52.9 mg/day. The mean value of serum magnesium levels was 2.04 ± 0.19 mg/dl. The mean of homeostatic model assessment of insulin resistance (HOMA-IR) was 4.82 ± 5.66. The lower level of the serum magnesium had a significant correlation with HOMA IR.


Conclusion: The nutrient intake containing magnesium is lower than recommendation. There is a significant negative correlation between the magnesium level and HOMA-IR on type 2 DM on metformin or pioglitazone.

Keywords: Homeostatic model assessment of insulin resistance,, Insulin resistance,, Serum magnesium levels,, Type 2 diabetes mellitus.

References

1. Bergman M. Pathophysiology of prediabetes and treatment implications for the prevention of Type 2 diabetes mellitus. Endocrine 2013; 43:504 13.
2. Gröber U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients 2015;7:8199-226.
3. Chhabra S, Chhabra S, Ramessur K, Chhabra N. Hypomagnesemia and its Implications in Type 2 Diabetes Mellitus a Review Article. Webmed Central Diabetes; 2012. Available from: https://www.webmedcentral. com/wmcpdf/Article_WMC004005.pdf. [Last accessed on 2017 June 14].
4. Günther T. The biochemical function of mg²+ in insulin secretion, insulin signal transduction and insulin resistance. Magnes Res 2010; 23:5-18.
5. Ghose B, Ide S. Hypomagnesemia and Type 2 diabetes mellitus: A review of literature. Austin J Nutr Food Sci 2014;2:1025.
6. Sales CH, Pedrosa LF, Lima JG, Lemos TM, Colli C. Influence of magnesium status and magnesium intake on the blood glucose control in patients with Type 2 diabetes. Clin Nutr 2011;30:359-64.
7. Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in Type 2 diabetes mellitus. Indian J Endocrinol Metabol 2012;16:1000-3.
8. Gupta NK, Sharma S, Kaushik GG, Gupta B. Association between indexs of insulin sensitivity/resistance and serum magnesium levels in overweight diabetic subjects. Indian J Clin Pract 2014;24:932-7.
9. Sadiq F, Nawaz MR. Hypomagnesemia in patients with Type 2 diabetes. Pak J Medial Sci 2014;8:983-5.
10. Rao P, Shariff MG. Serum magnesium levels in Type 2 diabetic patients with microalbuminuria and normoalbuminuria. Int J Sci Study 2015; 3:11-5.
11. Hans CP, Sialy R, Bansal DD. Magnesium deficiency and diabetes mellitus. Curr Sci 2002;83:1456-63.
12. Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH. Hypomagnesemia in Type 2 diabetes: A Vicious circle? Diabetes 2016; 65:3-13.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
14. Chutia H, Lynrah KG. Association of serum magnesium deficiency with insulin resistance in Type 2 diabetes mellitus. J Lab Physicians 2015; 7:75-8.
15. Infodatin (Pusat Data dan Informasi Kementerian Kesehatan RI). Situasi dan Analisis Diabetes; 2014. Available from: http://www.depkes.go.id/ resources/download/pusdatin/infodatin/infodatin-diabetes.pdf. [Last accessed on 2019 Jan 23].
16. Thevenod F. Pathophysiology of diabetes mellitus Type 2: Roles of obesity, insulin resistance and ?-cell dysfunction. Diabetes 2008;19:1 18.
17. Arafat MA, Salam A, Arafat O. The association of Type 2 diabetes with obesity and other factors: In multinational community. Int J Pharm Pharm Sci 2014;6:257-60.
18. Dietitian of Canada. Food Sources of Magnesium. Canadian Nutrient File; 2016. Available from: http://www.hc-sc.gc.ca/fn-an/nutrition/ fiche-nutri-data/index-eng.php. [Last accessed 2017 June 14].
19. Wälti MK, Zimmermann MB, Spinas GA, Jacob S, Hurrell RF. Dietary magnesium intake in Type 2 diabetes. Eur J Clin Nutr 2002;56:409-14.
20. Schmidt LE, Arfken CL, Heins JM. Evaluation of nutrient intake in subjects with non-insulin-dependent diabetes mellitus. J Am Diet Assoc 1994;94:773-4.
21. Tarigan TJ, Marbun MB, Harimurti K. Korelasi kadar magnesium serum dengan albuminuria pada pasien diabetes mellitus tipe 2. eJ Kedokt Indones 2015;3:115-9.
22. Green R, Milner J, Joy EJ, Agrawal S, Dangour AD. Dietary patterns in india: A systematic review. Br J Nutr 2016;116:142-8.
23. Plummer L. 50 Years of Food in India: Changing Eating Habits of a Rapidly Changing Nation of Foodies! In the Better India; 2017. Available From: http://www. Thebetterindia.com/98604/india-eating-a habits-food-50-years-culture. [Last accessed on 2019 Feb 13].
24. Monnier L, Colette C. Contributions of fasting and postprandial glucose to hemoglobin A1c. Endocr Pract 2006;12 Suppl 1:42-6.
25. Monnier L, Colette C, Owens D. Postprandial and basal glucose in Type 2 diabetes: Assessment and respective impacts. Diabetes Technol Ther 2011;13 Suppl 1:S25-32.
26. Ou HY, Cheng JT, Yu EH, Wu TJ. Metformin increases insulin sensitivity and plasma beta-endorphin in human subjects. Horm Metab Res 2006;38:106-11.
27. Rajagopalan S, Dutta P, Hota D, Bhansali A, Srinivasan A, Chakrabarti A. Effect of low dose pioglitazone on glycemic control and insulin resistance in Type 2 diabetes: A randomized, double blind, clinical trial. Diabetes Res Clin Pract 2015. Available from: http://www.dx.doi.org/10.1016/j. diabres.2015.05.030. [Last accessed on 2019 Jan 21].
28. Kartono AF, Irawati D, Setiawan AA, Syafutra H, Sumaryada T. The effects of physical exercise on the insulin-dependent diabetes mellitus subjects using the modified minimal model. Int J Pharm Pharm Sci 2017; 9:179-86.
Statistics
215 Views | 43 Downloads
How to Cite
HUWAINAN NISA NASUTION, SONY WIBISONO MUDJANARKO, DWI APRILAWATI, and AGUNG PRANOTO. “ASSOSIATION OF SERUM MAGNESIUM LEVELS WITH HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ON METFORMIN OR PIOGLITAZONE”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 12, no. 6, Apr. 2019, pp. 63-66, https://innovareacademics.in/journals/index.php/ajpcr/article/view/33061.
Section
Original Article(s)